Hiển thị các bài đăng có nhãn trial. Hiển thị tất cả bài đăng
Hiển thị các bài đăng có nhãn trial. Hiển thị tất cả bài đăng

Thứ Ba, 14 tháng 5, 2013

John Tomic assault trial postponed

John Tomic

John Tomic ... will now have to front court in Madrid in October. Source: JULIAN SMITH / AAP

The assault hearing involving the father and coach of Australian tennis player Bernard Tomic has been postponed because the man he is accused of headbutting said he couldn't attend.

John Tomic was to face court in Madrid on Tuesday night (EST) charged with the alleged assault of Tomic's training partner Thomas Drouet earlier this month.

But the Madrid court said the trial was postponed until October because Frenchman Drouet could not travel to Spain.

Drouet did not specify why he couldn't return for the hearing, casting some doubt over whether it will go ahead, though the court indicated it would.

"Since the plaintiff has not dropped the proceedings, the hearing is postponed for reasons of court scheduling until October,'' the court said in a statement.

John Tomic is free to leave Spain but will have to return for the trial, though no exact date has been set yet.

Drouet was left with a broken nose on May 4 after a brawl outside a hotel where players in the Madrid Masters were staying.

John Tomic denies assault and says he struck in self-defence, his lawyer Carmen Dieguez said.

Bernard Tomic, the world No.53, has made a poor start to this year's European clay court season and lost in straight sets to Czech veteran Radek Stepanek in the first round of the Madrid Masters.

He pulled out of the Rome Masters taking place this week, further disrupting his preparations for the French Open, starting on May 26.

Tomic Sr has been banned from attending ATP events in a coaching capacity pending further investigations into the incident.


View the original article here

Thứ Tư, 17 tháng 4, 2013

Makers of fraudulent breast implants on trial in France

  • Bra White.jpg

Hundreds of women who received faulty breast implants gathered Wednesday in a makeshift courthouse in the south of France for the fraud trial of five executives accused of using cheap industrial silicone to fill tens of thousands of implants that were sold around the world.

Jean-Claude Mas, who founded and ran implant-maker Poly Implant Prothese, is among those on trial in the southern city of Marseille. The now-defunct company had claimed its factory in France exported to more than 60 countries and was one of the world's leading implant makers.

The implants, which officials say are prone to rupture and leaking, were not sold in the United States, but more than 125,000 women worldwide received them until sales ended in March 2010. Of those, more than 5,000 are joining the trial as victims, saying the executives misled them into believing the implants were safe.

Nathalie De Michel, who received the implants, said Wednesday she wanted Mas to acknowledge responsibility.

"We have the impression that he doesn't care. I want him at least to recognize that he made mistakes. When you fight against cancer, you fight to survive, and if after they put some garbage in your body, what's the point of fighting for life?"
Mas declined comment as he entered the convention center — which was turned into a courthouse to host all those participating in the trial — in order to face the women for the first time.

The vast majority of the implants were for cosmetic reasons. The rest were for breast reconstruction, often following cancer surgery. Within France, about a quarter of the implants malfunctioned, most by rupturing and leaking silicone, according to a government tally released earlier this month.

Doctors and scientists who have followed the case say medical complications stemming from the ruptures and leaks appear to be limited even when the implants rupture: rashes and localized pain were the most common complaints. But lawyers for the women — more than 300 from around the world who joined the month-long trial — say the full effects will not be known for years to come.

Nataly Lozano, a Colombian lawyer who said she represents 1,500 women she says have had problems with the PIP implants, said she came to Marseille to seek justice for clients she says lack the resources to pay for follow-up care.

"I could name very difficult cases of women who don't even have means to undergo exams and know what state their implants are in," she said. "They know that they are dangerous implants and nevertheless they don't even have a way to know if their implants are broken inside their body, if eventually this substance will leak into their body."

The implants in question were not sold in the U.S., where concerns about silicone gel implants overall led to a 14-year ban on their use. Silicone implants were brought back to the market in 2006 after research ruled out cancer, lupus and some other concerns, but the FDA still cautions that implants of any kind can rupture or cause other problems.

The French government recommended that women have their PIP implants removed as a precaution, and about a third of Frenchwomen who had the implants did so, according to the April 2013 government report.

In Britain, the government left the choice up to women and their doctors, but recommended that the implants be removed if there was a sign of rupture.

The company ultimately went out of business, and regulators across Europe began demanding calls for tighter oversight of medical devices. Mas has said he is ruined financially.

According to various government estimates, over 42,000 women in Britain received the implants, more than 30,000 in France, 25,000 in Brazil and 15,000 in Colombia. Venezuela, where PIP implants were hugely popular, offered free removals for the estimated 16,000 women with the implants, as did France.

Mas, his deputy Claude Couty, the quality director Hannelore Font, technical director Loic Gossart, and products chief Thierry Brinon face the possibility of five years in prison if convicted.


Copyright © 2013 The Associated Press. All rights reserved.


View the original article here

ABORTION TRIAL: Family Recalls Philadelphia Doctor's Lack of Sympathy

  • mongar660.jpg

    This undated photo released by the Philadelphia District Attorney's Office shows Karnamaya Mongar, left, and her unidentified husband. (AP/Philadelphia District Attorney)

  • abortionclinicdeaths.jpg

    March 8, 2010: In this photo, Dr. Kermit Gosnell is seen during an interview with the Philadelphia Daily News at his attorney's office in Philadelphia.AP/Philadelphia Daily News

Twenty months in a refugee camp in war-torn Bhutan didn’t break Karnamaya Mongar. But the 41-year-old Virginia woman met her demise in 2009 after seeking an abortion from a Philadelphia doctor who could face the death penalty if convicted on seven counts of first-degree murder.

Through a Nepalese interpreter, Mongar’s daughter, Yashoda Gurung, testified Tuesday in the ongoing trial of Dr. Kermit Gosnell, 72, about the labor-inducing drugs and painkiller her mother was administered while awaiting the abortion provider to arrive for the second-trimester procedure. Gurung, 24, said she tried to wish her mother well before she was moved into the procedure room on Nov. 19, 2009, at the Women’s Medical Society clinic in West Philadelphia.

“My mom was sleeping,” Gurung told jurors through a translator. “That’s what I thought. I tried to wake her up and the lady said, ‘Leave her alone.’”

"I tried to wake her up and the lady said, ‘Leave her alone.'"

- Yashoda Gurung, daughter of victim

Prosecutors allege Gosnell’s untrained, unlicensed staff gave Mongar a fatal combination of oral and intravenous drugs and failed to properly monitor her vital signs. She went into cardiac arrest and a coma and died the following day. Gosnell’s attorney, Jack McMahon, has countered that Mongar, who was 19 weeks pregnant at the time, had unreported respiratory damage and died of complications.

Gosnell faces a third-degree murder charge in Mongar’s death. He is also charged with seven counts of first-degree murder for infants who were allegedly born alive and were killed by suffering severed spinal cords at Gosnell’s hands. The graphic trial, now in its fifth week, has led some conservative critics at the Media Research Center and other organizations to claim that most mainstream media outlets were slow to cover Gosnell’s alleged crimes because they run counter to supposed widely held support for abortion rights.

Damber Ghalley, Mongar’s brother, testified Tuesday he was told Mongar’s situation was “bad” when she arrived for the procedure. Ghalley said she spoke to Gosnell as she was being led to an ambulance.

“He said, ‘The procedure was done,” he told jurors. “Your sister’s heart stopped.”

Ghalley testified he saw Gosnell the following day outside the hospital where his sister died.

“He said the same thing: The procedure was done. I didn’t do anything wrong,” Ghalley said. “I would be able to answer [to] any person, anywhere. He did not express sympathy.”

Gosnell, who faces a wrongful-death lawsuit filed by Mongar’s relatives, is also charged with violating Pennsylvania’s abortion law for allegedly performing abortions after 24 weeks. Some observers have said the trial highlights the difficulty to get an abortion up to 24 weeks of pregnancy, or the end of the second trimester. A clinic near Mongar’s home in Woodbridge, Va., reportedly did not perform abortions after 14 weeks.

A janitor and handyman at the clinic -- which catered to minorities, the impoverished and women with late-term pregnancies -- also testified Tuesday, saying the facility had frequent plumbing problems and that toilets backed up weekly.

“I told the doc I would remove the toilet and lay it on its side, but somebody else would have to clean that out,” James Johnson testified.

Johnson’s shocking testimony solicited tears from some courtroom onlookers, including Day Gardner, president of the Washington-based National Black ProLife Coalition, the Philadelphia Inquirer reports.

In a petition on its website, the conservative Media Research Center called on broadcast networks to stop “censoring” coverage of the sensational trial. Networks like ABC and NBC have given the story “zero coverage” during morning and evening shows and CBS finally ended its coverage blackout on April 15, a month after opening arguments began, MRC officials claim.

“It is clear why the liberal media would not want this story to get out — because it would expose the American people to the truth about the horrific and ghastly practices of abortionists and compel everyone with a sense of decency to call for an end to such practices,” the petition read. “But that is in direct opposition to the liberal media's agenda — and that is why they won't cover it.”

The petition also cited an op-ed that appeared in USA Today on April 11 by columnist Kirsten Powers, who is also a Fox News contributor.

"Infant beheadings. Severed baby feet in jars. A child screaming after it was delivered alive during an abortion procedure,” Powers wrote. “Haven't heard about these sickening accusations?”

A Lexis-Nexis search of the news shows on the three major television networks found that none had mentioned the Gosnell trial in the last three months. The lone exception was Wall Street Journal columnist Peggy Noonan’s take on a "Meet the Press" segment, according to Powers.

"It's not your fault,” Powers continued. “Since the murder trial of Pennsylvania abortion doctor Kermit Gosnell began March 18, there has been precious little coverage of the case that should be on every news show and front page."

The Associated Press contributed to this report.


View the original article here

Thứ Ba, 26 tháng 3, 2013

Italy's top court overturns Amanda Knox acquittal in murder case, orders new trial- VIDEO: How strong is the case against Knox?

Italy's highest criminal court on Tuesday overturned the acquittal of Amanda Knox in the slaying of her British roommate and ordered a new trial, prolonging a case that has become a cause celebre in the U.S.

The Court of Cassation ruled that an appeals court in Florence must re-hear the case against the American and her Italian-ex-boyfriend for the murder of 21-year-old Meredith Kercher. The exact issues that have to be reconsidered won't be known until the court releases its full ruling.

Lawyers for Knox and her ex-boyfriend Raffaele Sollecito looked grim as they huddled with prosecutors and court officials to get details after the ruling was issued. Lawyers for the Kercher family said they had got what they wanted.

Kercher's body was found in November 2007 in her bedroom of the house she shared with Knox and others in Perugia, an Italian university town where the two women were exchange students. Her throat had been slashed.

Prosecutors alleged Kercher was the victim of a drug-fueled sex game gone awry. Knox and Sollecito denied wrongdoing and said they weren't even in the apartment that night, though they acknowledged they had smoked marijuana and their memories were clouded.

An Ivory Coast man, Rudy Guede, was convicted of the slaying in a separate proceeding and is serving a 16-year sentence. Knox and Sollecito were also initially convicted of the murder and given long prison sentences, but were then acquitted on appeal and released.

The high court's ruling Tuesday overturns the appeals court acquittals.

Italian law cannot compel Knox to return from the U.S. for the new trial. The appellate court hearing the case could declare her in contempt of court but that carries no additional penalties.

It is unclear what would happen if she was convicted in a new appeals trial.

"If the court orders another trial, if she is convicted at that trial and if the conviction is upheld by the highest court, then Italy could seek her extradition," Knox's lawyer Carlo Dalla Vedova said Monday.

It would then be up to the United States to decide if it honors the request. U.S. and Italian authorities could also come to a deal that would keep Knox in the United States.

Knox, now 25, and Sollecito, who turned 29 on Tuesday, were arrested shortly after Kercher's body was found in a pool of blood.

The appeals court that acquitted them in 2011 criticized virtually the entire case mounted by prosecutors. The appellate court noted that the murder weapon was never found, said that DNA tests were faulty and that prosecutors provided no murder motive.

After nearly four years behind bars in Italy, Knox returned to her hometown of Seattle and Sollecito resumed his computer science studies, following the degree he successfully earned while studying in prison.

Knox is now a student at the University of Washington, according to her family spokesman, Dave Marriott.

Italy's judicial system allows for two levels of appeals, and prosecutors can appeal acquittals.

Although the court on Monday heard gruesome details, including how Kercher choked on her own blood, it wasn't ruling on the guilt or innocence of the defendants. Its sole task was to decide if the appellate trial was properly conducted.

Details of the ruling weren't issued Tuesday and won't be for several weeks.


View the original article here

Thứ Hai, 4 tháng 3, 2013

Drug shown to be effective, safe in psoriasis trial

Celgene Corp's experimental drug apremilast proved to be more effective than a dummy pill for psoriasis patients in a late-stage study, clearing the way for the company to file for U.S. regulatory approval in the second half of 2013.

Celgene said 59 percent of patients in the 844-patient trial achieved a 50 percent improvement in symptoms at 16 weeks, using a standard score of the severity and extent of psoriasis, compared with 17 percent of placebo patients. A 75 percent improvement in symptoms was seen in 33 percent of the treatment group and 5 percent of the placebo group.

The Phase 3 trial is the first of two pivotal studies of the drug in patients with psoriasis, a disease in which itchy, painful skin plaques are thought to be caused by an inflammatory response initiated by the body's immune system.

Apremilast is a pill that inhibits an enzyme known as phosphodiesterase 4, or PDE4, and acts to damp down inflammation.

Celgene said previously it planned to file for Food and Drug Administration approval of the drug as a treatment for psoriatic arthritis in the first quarter of this year.

Side effects were consistent with those seen in earlier trials of the drug, with the most common being diarrhea and nausea.

Celgene said no cases of tuberculosis or lymphoma were observed through Week 16, and there was no increase in risk of cardiovascular events or serious opportunistic infection.

"From a physician's perspective, this can definitely be a first-line therapy because of the excellent risk/benefit profile," said Dr. Richard Langley, director of dermatology research at Dalhousie University inHalifax, and one of the study's lead investigators. "I think the patient acceptance of this drug and the physician acceptance is going to be extremely high."

He noted that most psoriasis patients are currently treated with methotrexate, which can cause serious side effects.

Newer biologic drugs used to treat psoriasis, which include Amgen Inc's Enbrel and AbbVie Inc's Humira, can make patients more susceptible to infection, Dr. Langley said.


View the original article here

Suit over hiring of Michael Jackson's doctor to go to trial

A judge has dismissed all but one count in a civil lawsuit by Michael Jackson's mother against concert giant AEG Live, which hired a doctor who was convicted of involuntary manslaughter in the singer's death.

Superior Court Judge Yvette Palazuelos' ruling Thursday means that Katherine Jackson will have a trial on her claim that AEG negligently hired and supervised former cardiologist Conrad Murray. The ruling dismisses claims that AEG could be held liable for Murray's conduct and breached its duty to properly care for the pop superstar.

AEG Live was promoting a series of comeback concerts by Michael Jackson in London titled "This Is It." Jackson died in June 2009 while in final preparations for the shows after Murray administered a lethal dose of the anesthetic propofol in the singer's bedroom.

Katherine Jackson's attorney Kevin Boyle was not immediately available for comment but argued at a hearing Monday that AEG controlled Murray's actions and failed to properly investigate him before agreeing to pay him to work as the singer's physician.

He cited Murray's debt problems as a red flag that AEG should have spotted and contends the company created a serious conflict between his responsibility to Jackson and his own financial well-being.

Jackson died at age 50 before a contract that would have paid Murray $150,000 a month was finalized.

AEG attorney Marvin Putnam has said Murray was not employed by the promoter and he expects the company to win at trial. He said Katherine Jackson's lawyers will be unable to prove that AEG should have foreseen that Murray was a danger to the "Thriller" singer.

A trial is scheduled to begin April 2.


View the original article here

Thứ Sáu, 1 tháng 3, 2013

Judge: Lindsay Lohan will go to trial March 18 for lying to police

Lindsay Lohan may want to make nice with her old lawyer, Shawn Chapman Holley.

All motions made by Lohan's new New York City lawyer, Mark Heller, to delay or do away with altogether the actress' scheduled March 18 trial were denied today by a Southern California Judge, who scolded the attorney for not being in compliance with California court procedures.

Which means Lohan's trial on charges of reckless driving and lying to police about a car crash she was in last year, is on.

Los Angeles Superior Court Judge James Dabney said there is no good reason to delay the case.

He also told Heller he needed to bring a lawyer with him on March 18 who can guide him through the differences between New York and California procedures. 

Dabney said either someone assists him who is competent in criminal law in California, or Lohan waives her right to say she wasn't adequately represented.

Heller was seeking a delay to prepare his defense, and to allow her more time to undergo psychotherapy counseling and perform community service.

Heller's motion to dismiss the case outright because, he contends, Lohan wasn't read her Miranda rights by the Santa Monica police was also denied. Dabney said that was a matter for the trial.

After the hearing, Heller and the prosecutor went into a conference room for a private meeting.

Lohan did not attend the hearing.

The "Mean Girls" actress has pleaded not guilty to the misdemeanor charges that also include obstructing officers from performing their duties while investigating the June crash.

Lohan was on probation at the time of the crash and could face up to 245 days in jail if a judge determines she violated the terms of her sentence in a 2011 necklace theft case.


View the original article here